Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers-Reference-Cited by-同舟云学术

Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers

Published:2021-02-01 Issue:2 Volume:181 Page:195
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Abella Benjamin S.¹,Jolkovsky Eliana L.¹,Biney Barbara T.¹,Uspal Julie E.¹,Hyman Matthew C.²,Frank Ian³,Hensley Scott E.⁴,Gill Saar⁵,Vogl Dan T.⁵,Maillard Ivan⁵,Babushok Daria V.⁵,Huang Alexander C.⁵,Nasta Sunita D.⁵,Walsh Jennifer C.⁵,Wiletyo E. Paul⁶,Gimotty Phyllis A.⁶,Milone Michael C.⁷,Amaravadi Ravi K.⁵,

Affiliation:

1. Department of Emergency Medicine, University of Pennsylvania, Philadelphia

2. Division of Cardiology, Department of Medicine University of Pennsylvania, Philadelphia

3. Division of Infectious Disease, Department of Medicine University of Pennsylvania, Philadelphia

4. Department of Microbiology, University of Pennsylvania, Philadelphia

5. Abramson Cancer Center and Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia

6. Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia

7. Department of Pathology, University of Pennsylvania, Philadelphia

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2771265/jamainternal_abella_2020_oi_200089_1611344111.08576.pdf

Reference23 articles.

1. Estimation of excess deaths associated with the COVID-19 pandemic in the United States, March to May 2020.;Weinberger;JAMA Intern Med,2020

2. Spatial disparities in coronavirus incidence and mortality in the United States: An ecological analysis as of May 2020.;Zhang;J Rural Health,2020

3. Disproportionate impact of COVID-19 on racial and ethnic minorities in the United States.;Tai;Clin Infect Dis

4. Impact of comorbidities on patients with COVID-19: a large retrospective study in Zhejiang, China.;Ye;J Med Virol

5. A cross-sectional study of immune seroconversion to SARS-CoV-2 in frontline maternity health professionals.;Bampoe;Anaesthesia,2020

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial;PLOS Medicine;2024-09-12

2. Drupacine as a potent SARS-CoV-2 replication inhibitor in vitro;Biosafety and Health;2024-09

3. EFICÁCIA DA CLOROQUINA E HIDROXICLOROQUINA NA PROFILAXIA E TERAPIA DA COVID-19 - UMA REVISÃO SISTEMÁTICA;REVISTA FOCO;2024-07-29

4. SLC38A9 regulates SARS-CoV-2 viral entry;iScience;2024-07

5. Preimplantation development of in vitro-produced bovine embryos treated with hydroxychloroquine;Toxicology in Vitro;2024-06